Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy

Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy

© Copyright 2015, Mary Ann Liebert, Inc. 2015. Tenofovir (TFV) exposure is associated with antiretroviral efficacy and risk of kidney disease. There is evidence of high interindividual variability of the pharmacokinetics of TFV. The effect of several clinical conditions on the pharmacokinetics of TF...

Saved in:

書目詳細資料
Main Authors:	Stephen J. Kerr, Baralee Punyawudho, Narukjaporn Thammajaruk, Angela Colbers, Prachya Chaiyahong, Supalak Phonphithak, Vorapot Sapsirisavat, Kiat Ruxrungtham, David M. Burger, Anchalee Avihingsanon
格式:	雜誌
出版:	2018
主題:	Immunology and Microbiology Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84951574879&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54579
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapy
由: Stephen J. Kerr, et al.
出版: (2018)

Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
由: Kanokrat Rungtivasuwan, et al.
出版: (2018)

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
由: Kanokrat Rungtivasuwan, et al.
出版: (2018)

Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
由: Kanokrat Rungtivasuwan, et al.
出版: (2018)

Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients
由: Kanokrat Rungtivasuwan, et al.
出版: (2018)

Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients
由: Kanokrat Rungtivasuwan, et al.
出版: (2018)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Pharmaceutical equivalence drugs assessment-I (PEDA-I) : assess the pharmaceutical equivalence of generic antiretrovirals distributed in Thailand : Final report
由: Kiat Ruxrungtham, et al.
出版: (2016)

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients
由: Punyawudho B., et al.
出版: (2017)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
由: Vera E. Bukkems, et al.
出版: (2020)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
由: Torsak Bunupuradah, et al.
出版: (2018)

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients
由: Noppaket Singkham, et al.
出版: (2019)

Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients
由: Noppaket Singkham, et al.
出版: (2020)

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
由: Noppaket Singkham, et al.
出版: (2022)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Punyawudho B., et al.
出版: (2017)

ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen
由: Weerawat Manosuthi, et al.
出版: (2018)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
由: Weerawat Manosuthi, et al.
出版: (2018)

Improvement of Mycoepoxydiene production by Endophytic fungus Phomopsis sp. Hants25 isolate from Hydnocarpus anthelminthicus
由: Narukjaporn Thammajaruk
出版: (2009)

Up to 79% of travelers with high STIs risk visiting Thailand have casual sex with an average of 10 sex partners
由: Vorapot Sapsirisavat, et al.
出版: (2020)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
由: Avihingsanon A.
出版: (2023)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
由: Tim R. Cressey, et al.
出版: (2018)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
由: Tim R. Cressey, et al.
出版: (2018)

Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
由: Linda Aurpibul, et al.
出版: (2019)

Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting
由: Weerawat Manosuthi, et al.
出版: (2018)

Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
由: Hylke Waalewijn, et al.
出版: (2019)

Antiretroviral drug taking among Myanmar migrants in Central Region of Thailand
由: Nilar Han
出版: (2012)

Antiretroviral drug taking among Myanmar migrants in Central Region of Thailand
由: Nilar Han
出版: (2008)

Take a break! Benefits of sleep and short breaks for daily work engagement
由: KUHNEL, Jana, et al.
出版: (2017)

Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective study
由: Weerawat Manosuthi, et al.
出版: (2018)

Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand
由: Wisit Prasithsirikul, et al.
出版: (2019)

Comparison of thai government manufactured tenofovir (Tenofovir GPO300) with privately manufactured tenofovir (Viread) used along with lamivudine and efavirenz to treat Thai HIV patients
由: Weerawat Manosuthi, et al.
出版: (2018)

Association between polymorphisms of tenofovir transporters and tenofovir plasma levels in Thai HIV-infected patients
由: Siwaporn Mitruk
出版: (2013)

TSH, FT4, and CD4 Profile in HIV/AIDS Patients Before and After Antiretroviral Fixed-Dose Combination Tenofovir, Lamivudine, Evafirenz Therapy
由: Djati Susilo, -, et al.
出版: (2020)

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
由: Avihingsanon A.
出版: (2023)

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial
由: Pedro Cahn, et al.
出版: (2018)

Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in Thailand
由: Piyawat Chaivichacharn, et al.
出版: (2020)